Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 6—June 2023
Research

SARS-CoV-2 Seroprevalence Studies in Pets, Spain

Sandra Barroso-Arévalo, Lidia Sánchez-Morales, Jose A. Barasona, Lucas Domínguez, and José M. Sánchez-Vizcaíno
Author affiliations: VISAVET Health Surveillance Center, Madrid, Spain (S. Barroso-Arévalo, L. Sánchez-Morales, J.A. Barasona, L. Domínguez, J.M. Sánchez-Vizcaíno); Complutense University of Madrid, Madrid (S. Barroso-Arévalo, J.A. Barasona, L. Domínguez, J.M. Sánchez-Vizcaíno)

Main Article

Figure 2

Predicted probability of SARS-CoV-2 seroprevalence in pets as related to registered human incidence (cases per 100,000 inhabitants) at the province-period (3 months each period) level in study of SARS-CoV-2 seroprevalence studies in pets, Spain. The black line marks the trend and slope of the correlation. Lighter gray lines show 95% CIs.

Figure 2. Predicted probability of SARS-CoV-2 seroprevalence in pets as related to registered human incidence (cases per 100,000 inhabitants) at the province-period (3 months each period) level in study of SARS-CoV-2 seroprevalence studies in pets, Spain. The black line marks the trend and slope of the correlation. Lighter gray lines show 95% CIs.

Main Article

Page created: April 04, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external